quinuclidines has been researched along with lithium chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freedman, SB; Patel, S | 1 |
| Limebeer, CL; Litt, DE; Parker, LA | 1 |
2 other study(ies) available for quinuclidines and lithium chloride
| Article | Year |
|---|---|
The muscarinic receptor agonist L-658,903 modulates the in vivo accumulation of inositol monophosphates in mouse brain.
Topics: Animals; Binding Sites; Brain; Dose-Response Relationship, Drug; In Vitro Techniques; Inositol Phosphates; Lithium Chloride; Male; Mice; N-Methylscopolamine; Oxadiazoles; Oxotremorine; Parasympatholytics; Pilocarpine; Quinuclidines; Receptors, Muscarinic; Scopolamine; Scopolamine Derivatives | 1994 |
Effect of 5-HT3 antagonists and a 5-HT(1A) agonist on fluoxetine-induced conditioned gaping reactions in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiemetics; Autoreceptors; Conditioning, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Isoquinolines; Lithium Chloride; Male; Nausea; Ondansetron; Palonosetron; Quinuclidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2009 |